FDA Inspection 886173 — GSK LLC (GlaxoSmithKline)
The FDA completed an inspection of GSK LLC (GlaxoSmithKline) on June 3, 2014 in Collegeville, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 3, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Collegeville, PA (United States)
Additional Details
Sponsor, Contract Research Organization